Athna Biotech, Inc. received a Phase I Small Business Innovation Research (SBIR) grant from NIH NCI to develop a salt-based nanomedicine for non-muscle invasive bladder cancer.
Athna Biotech, Inc. received a Phase I Small Business Technology Transfer (STTR) grant from NIH NCI to develop a radiation-activatable nanoparticle for lung cancer therapy.
We use cookies to analyze website traffic and optimize your website experience. By accepting our use of cookies, your data will be aggregated with all other user data.